X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2586) 2586
Book Chapter (24) 24
Book / eBook (10) 10
Magazine Article (9) 9
Web Resource (2) 2
Publication (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1551) 1551
atrial fibrillation (978) 978
female (843) 843
male (824) 824
cardiac & cardiovascular systems (812) 812
aged (675) 675
stroke (675) 675
risk factors (651) 651
middle aged (566) 566
warfarin (446) 446
peripheral vascular disease (391) 391
anticoagulants (383) 383
atrial fibrillation - drug therapy (377) 377
atrial fibrillation - complications (372) 372
anticoagulants - therapeutic use (344) 344
abridged index medicus (303) 303
stroke - prevention & control (302) 302
risk (277) 277
mortality (272) 272
management (264) 264
aged, 80 and over (253) 253
prevention (249) 249
hypertension (247) 247
cardiovascular (240) 240
stroke - etiology (236) 236
treatment outcome (236) 236
medicine, general & internal (235) 235
stroke prevention (229) 229
thromboembolism (228) 228
cardiac arrhythmia (226) 226
risk assessment (226) 226
prognosis (218) 218
anticoagulation (216) 216
care and treatment (198) 198
atrial fibrillation - epidemiology (196) 196
heart failure (192) 192
anticoagulants - adverse effects (190) 190
therapy (188) 188
hematology (181) 181
aspirin (178) 178
adult (176) 176
anticoagulants - administration & dosage (176) 176
follow-up studies (167) 167
stroke - epidemiology (167) 167
administration, oral (160) 160
atrial fibrillation - diagnosis (154) 154
cardiology (153) 153
dabigatran (150) 150
antithrombotic therapy (149) 149
fibrillation (143) 143
incidence (139) 139
hemorrhage - chemically induced (136) 136
guidelines (135) 135
prevalence (133) 133
drug therapy (131) 131
oral anticoagulation (130) 130
analysis (129) 129
bleeding (129) 129
warfarin - therapeutic use (127) 127
internal medicine (126) 126
prospective studies (126) 126
thrombosis (126) 126
atrial fibrillation - therapy (124) 124
disease (124) 124
patients (123) 123
registries (119) 119
biomarkers - blood (115) 115
cohort studies (115) 115
myocardial-infarction (112) 112
risk-factors (111) 111
atrial fibrillation - physiopathology (110) 110
atrial-fibrillation (109) 109
clinical neurology (109) 109
ischemic-stroke (109) 109
research (109) 109
rivaroxaban (108) 108
thromboembolism - prevention & control (108) 108
predicting stroke (107) 107
health aspects (105) 105
von-willebrand-factor (105) 105
atrial fibrillation - mortality (102) 102
pharmacology & pharmacy (100) 100
time factors (99) 99
acute myocardial-infarction (98) 98
comorbidity (98) 98
retrospective studies (96) 96
outcomes (95) 95
c-reactive protein (93) 93
fibrinolytic agents - therapeutic use (93) 93
atrial fibrillation - blood (92) 92
european-society (91) 91
metaanalysis (91) 91
population (91) 91
cardiovascular disease (90) 90
heart (90) 90
cardiology and cardiovascular medicine (89) 89
cardiovascular diseases (89) 89
cross-sectional studies (88) 88
oral anticoagulants (88) 88
safety (87) 87
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2607) 2607
Spanish (19) 19
Japanese (9) 9
Italian (5) 5
Polish (4) 4
Portuguese (3) 3
French (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2010, ISBN 9781846920462, ix, 214
Aimed at doctors with a general interest in cardiology as well as specialists. "Problem Solving in Cardiology" will appeal to a wide audience of physicians who... 
Heart Diseases
Book
Hypertension, ISSN 0194-911X, 09/2016, Volume 68, Issue 3, pp. 544 - 545
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2012, Volume 60, Issue 8, pp. 738 - 746
Objectives This study sought to perform an indirect comparison analysis of dabigatran etexilate (2 doses), rivaroxaban, and apixaban for their relative... 
Cardiovascular | Internal Medicine | indirect comparisons | dabigatran | atrial fibrillation | rivaroxaban | apixaban | stroke prevention | NETWORK | CARDIAC & CARDIOVASCULAR SYSTEMS | EVENTS | METAANALYSIS | RISK | THERAPY | WARFARIN | ASSOCIATION | Thiophenes - therapeutic use | Pyrazoles - therapeutic use | Anticoagulants - administration & dosage | Thiophenes - adverse effects | Humans | Middle Aged | Male | Thiophenes - administration & dosage | Dabigatran | Pyridones - administration & dosage | Rivaroxaban | Clinical Trials, Phase III as Topic | Pyridines - adverse effects | Benzimidazoles - administration & dosage | Female | Benzimidazoles - adverse effects | Odds Ratio | Morpholines - adverse effects | Morpholines - therapeutic use | Benzimidazoles - therapeutic use | Pyrazoles - adverse effects | Pyridines - therapeutic use | Stroke - prevention & control | Pyridines - administration & dosage | Administration, Oral | Morpholines - administration & dosage | Atrial Fibrillation - complications | Anticoagulants - therapeutic use | Treatment Outcome | Anticoagulants - adverse effects | Pyrazoles - administration & dosage | Stroke - etiology | Aged | Pyridones - therapeutic use | Hemorrhage - chemically induced | Pyridones - adverse effects | Stroke (Disease) | Usage | Analysis | Atrial fibrillation | Anticoagulants (Medicine) | Universities and colleges | Cardiology | Anticoagulants | Cardiac arrhythmia | Stroke | Drug therapy
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2013, Volume 62, Issue 11, pp. 981 - 989
Journal Article